DeFronzo RA - Search Results

1

What is the best predictor of future type 2 diabetes?

Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. Abdul-Ghani MA, et al. Among authors: defronzo ra. Diabetes Care. 2007 Jun;30(6):1544-8. doi: 10.2337/dc06-1331. Epub 2007 Mar 23. Diabetes Care. 2007. PMID: 17384342

2

Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance.

Cusi K, DeFronzo R. Cusi K, et al. J Clin Endocrinol Metab. 2000 Sep;85(9):3077-84. doi: 10.1210/jcem.85.9.6827. J Clin Endocrinol Metab. 2000. PMID: 10999789 Clinical Trial.

3

Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes.

Pratipanawatr T, Cusi K, Ngo P, Pratipanawatr W, Mandarino LJ, DeFronzo RA. Pratipanawatr T, et al. Among authors: defronzo ra. Diabetes. 2002 Feb;51(2):462-8. doi: 10.2337/diabetes.51.2.462. Diabetes. 2002. PMID: 11812756

4

Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes.

Miyazaki Y, Matsuda M, DeFronzo RA. Miyazaki Y, et al. Among authors: defronzo ra. Diabetes Care. 2002 Mar;25(3):517-23. doi: 10.2337/diacare.25.3.517. Diabetes Care. 2002. PMID: 11874940 Clinical Trial.

5

Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes.

Bajaj M, Pratipanawatr T, Berria R, Pratipanawatr W, Kashyap S, Cusi K, Mandarino L, DeFronzo RA. Bajaj M, et al. Among authors: defronzo ra. Diabetes. 2002 Oct;51(10):3043-8. doi: 10.2337/diabetes.51.10.3043. Diabetes. 2002. PMID: 12351445 Clinical Trial.

6

Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus.

Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Among authors: defronzo ra. Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1135-43. doi: 10.1152/ajpendo.0327.2001. Am J Physiol Endocrinol Metab. 2002. PMID: 12424102 Free article. Clinical Trial.

7

Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.

Miyazaki Y, Pipek R, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Among authors: defronzo ra. Int J Obes Relat Metab Disord. 2003 Jan;27(1):88-94. doi: 10.1038/sj.ijo.0802187. Int J Obes Relat Metab Disord. 2003. PMID: 12532159

8

Further evidence for a type 2 diabetes susceptibility locus on chromosome 11q.

Duggirala R, Almasy L, Blangero J, Jenkinson CP, Arya R, DeFronzo RA, Stern MP, O'Connell P; American Diabetes Association GENNID Study Group. Duggirala R, et al. Among authors: defronzo ra. Genet Epidemiol. 2003 Apr;24(3):240-2. doi: 10.1002/gepi.10233. Genet Epidemiol. 2003. PMID: 12652528 No abstract available.

9

Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.

Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA. Bajaj M, et al. Among authors: defronzo ra. Diabetes. 2003 Jun;52(6):1364-70. doi: 10.2337/diabetes.52.6.1364. Diabetes. 2003. PMID: 12765945

10

Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.

Miyazaki Y, He H, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Among authors: defronzo ra. Diabetes. 2003 Aug;52(8):1943-50. doi: 10.2337/diabetes.52.8.1943. Diabetes. 2003. PMID: 12882909 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters